This Stock Surges 26.5 percent in a Week A Lesson in Staying Ahead with InvestingPro By Investing.com - Investing.com India

KREBSBIO   107.80  2.37  2.15%   
Under 61% of Krebs Biochemicals' investor base is looking to short. The analysis of overall sentiment of trading Krebs Biochemicals and stock suggests that many investors are alarmed at this time. Krebs Biochemicals' investing sentiment shows overall attitude of investors towards Krebs Biochemicals and.
  
This Stock Surges 26.5 percent in a Week A Lesson in Staying Ahead with InvestingPro By Investing.com Investing.com India

Read at news.google.com
Google News at Macroaxis
  

Krebs Biochemicals Fundamental Analysis

We analyze Krebs Biochemicals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Krebs Biochemicals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Krebs Biochemicals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Beta

Beta Comparative Analysis

Krebs Biochemicals is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

Krebs Biochemicals and Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Krebs Biochemicals stock to make a market-neutral strategy. Peer analysis of Krebs Biochemicals could also be used in its relative valuation, which is a method of valuing Krebs Biochemicals by comparing valuation metrics with similar companies.

Complementary Tools for Krebs Stock analysis

When running Krebs Biochemicals' price analysis, check to measure Krebs Biochemicals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Krebs Biochemicals is operating at the current time. Most of Krebs Biochemicals' value examination focuses on studying past and present price action to predict the probability of Krebs Biochemicals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Krebs Biochemicals' price. Additionally, you may evaluate how the addition of Krebs Biochemicals to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities